Value Adds in the Cannabis Space
I have an article up at Seeking Alpha on adding value in the cannabis space.
Tag: cannabis
FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal
– FSD enters into 3-way supply agreement to purchase up to 1,000 kg of 2018 hemp crop –
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD”), a licensed producer under the Cannabis Act, announced today that it has entered into a supply agreement (the “Agreement”) with Canntab Therapeutics Ltd. (“Canntab”) and World Class Extractions Inc. (“World Class”) (the “Purchasers”) to purchase hemp flower from Thomas Elcome (the “Supplier”). Pursuant to the agreement, the Purchasers have agreed to buy approximately 1,000 kg of the Supplier’s 2018 hemp crop at a purchase price of $100.00 per kg per 1% of CBD extracted from the flower.
FSD Pharma responds to and corrects misleading Auxly claims
FSD Pharma Inc.(CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) a licensed producer under the Cannabis Act, responded today to a press release by its former partner, Auxly Cannabis Group Inc. (“Auxly”) to correct misleading claims.
Cannara Biotech Enters Cannabinoid-Infused Beverage Product Category
Partners with a Leading Quebec Microbrewery
Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE), a Montreal-based company that is building a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced it has entered into a letter of intent with a leading Quebec microbrewery to develop cannabinoid-infused beverages. Following the regulations relating to edibles and beverages coming into effect next October, consumers will be able to purchase a variety of cannabinoid-infused beverages including non-alcoholic beer, kombucha and cider.
FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips
– FSD receives exclusive, perpetual license to manufacture and sell oral film strips in CanadaFSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company), a licensed producer under the Cannabis Act, announced today that it has completed a strategic investment of $1.5 million in Pharmastrip Corp. and signed a definitive collaboration and profit sharing agreement with the company, effective January 23, 2019. Under the terms of the agreement, FSD will install Pharmastrip proprietary equipment at its facility in Cobourg, Ontario. FSD will use the equipment to manufacture organic medical cannabis infused in oral thin film strips. Pharmastrip will grant FSD an exclusive, perpetual license to manufacture and sell the oral thin film strips in Canada.
FSD Pharma Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae
PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(SFSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (“FSD Pharma“) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest“) (collectively, the “Parties“), a technology company which has developed an algal-based flexible production platform capable of producing health products, are pleased to announce that they have signed a non-binding letter of intent (“LOI“). The parties intend to enter into a definitive agreement (the “Collaborative Research Agreement“), under which Solarvest would conduct research using its algal expression technology to develop pharma-grade cannabinoids (the “Project Cannabinoids“), the Parties would make mutual investments into one another, and Solarvest would grant FSD Pharma an exclusive license over a subset of the Project Cannabinoids and certain royalty rights over all of the other Project Cannabinoids.
FSD Pharma Congratulates High Tide Inc. for Signing LOI with Winner of Ontario Retail License Lottery to Operate Cannabis Retail Store
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: OK9) (“FSD Pharma” or the “Company”) would like to congratulate High Tide Inc. (“High Tide”) for entering into a letter of intent with a winner of one of the 25 opportunities to apply for a license to operate a cannabis retail store (the “Winner”) as a result of the Alcohol and Gaming Commission of Ontario’s Expression of Interest Application Lottery conducted on January 11, 2019. Under the terms of the LOI, High Tide will acquire a minority interest in the Winner and will assist the Winner with establishing and operating a cannabis retail store in Ontario.
HUGE Executive Co-Chairman Durkacz on Midas
Excellent interview with Anthony Durkacz Co-Chair of FSD Pharma on Midas Report:
HUGE article up at Seeking Alpha
I have a new article on the Canadian Cannabis market and the idea of adding value in the marijuana space up at Seeking Alpha.
FSD Pharma (C.HUGE) Co-Chair Speaks
I like Anthony Durkacz. I’ve interviewed him several times for motherlodetv.net and he is very straightforward and tells the HUGE story well.